An interventional study of FOCUS Individualized Family Resiliency Training in Veteran Families, Family Communications and Civilian Life Reintegration, sponsored by University of California, Los Angeles. Withdrawn at 1 site in United States. Open to participants aged 5 Years and older. Per ClinicalTrials.gov, last updated 2022-11-03.
Sponsored by University of California, Los Angeles · Not applicable, Interventional, and Supportive care
The study will examine the effectiveness of an eight session, manualized individual family resiliency training (IFRT) for families with one OEF/OIF/OND veteran in promoting better family communication relating to return to post military life.
University of California, Los Angeles is the lead sponsor of 1,142 studies on the registry; 192 are open to participants now.
Of its 91 completed or terminated interventional studies of FDA-regulated products, 66 (73%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Subjects are randomized to receive immediate intervention of the 8 session FOCUS IFRT
Behavioral: FOCUS Individualized Family Resiliency Training
Subjects are randomized to be waitlisted for 4 months, re-assessed and then receive intervention of the 8 session FOCUS IFRT
Behavioral: FOCUS Individualized Family Resiliency Training
Eight session psycho educational training for families to enhance communication and reduce stressors related to return to post-military life.
Improvement on standardized behavioral health assessment scales
Time frame: 4-6 months
This study is withdrawn, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, Los Angeles